News from takeda pharmaceutical company limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

08 Dec, 2011, 15:17 GMT Takeda's Edarbi® (azilsartan medoxomil) Receives European Marketing Authorisation for the Treatment of Essential Hypertension

Takeda Pharmaceutical Company Limited (Takeda) today announced that the European Commission has granted marketing authorisation for Edarbi®...


21 Oct, 2011, 12:02 BST Further European Regulatory Review Clarifies and Confirms Prior CHMP Position on Positive Benefit-Risk Balance for Pioglitazone-Containing Products

European Medicines Agency recognizes that Takeda's pioglitazone-containing medicines remain a valid treatment option for appropriate type 2 diabetes...


30 Sep, 2011, 12:00 BST Takeda Completes Acquisition and Names New CEO of Nycomed

Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced it has completed its acquisition of Nycomed A/S ("Nycomed") for 9.6 billion...


27 Jun, 2011, 08:00 BST Takeda Announces EMA Acceptance of Marketing Authorization Application for ADCETRIS(TM) (Brentuximab Vedotin)

Takeda Pharmaceutical Company Limited (TSE:4502) together with its wholly-owned subsidiary Millennium: The Takeda Oncology Company, today announced...


19 May, 2011, 09:22 BST Takeda to Acquire Nycomed

Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) and Nycomed A/S ("Nycomed") jointly announced today that Takeda has reached an agreement...


01 Apr, 2011, 08:00 BST Takeda Appoints New CEO for European Commercial Business

Takeda Pharmaceutical Company Limited ("Takeda") announced that effective April 1, Trevor Smith, currently Vice President, International Strategy,...